AB

Aryav Bablani

Director Director DIN 09607871
DIN 09607871 First appointment May 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2022
Shareholding value Locked Premium profile

About Aryav Bablani

Data last updated:

Aryav Bablani has 4 years in corporate governance. Formerly with 1 company, such as Aerexaa Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09607871
Primary Designation Director
First Appointment 17 May 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Aerexaa Lifesciences Private Limited U24299DL2022PTC398429
Director17 May 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aerexaa Lifesciences Private Limited
Premium access

Shareholding and investment profile for Aryav Bablani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aryav Bablani

Aryav Bablani has 4 years in corporate governance. Formerly with 1 company, such as Aerexaa Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.

Aryav Bablani is associated with 0 companies as a director.

Aryav Bablani has expertise in General Business.

Aryav Bablani has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available